Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AI71 is a newly launched artificial intelligence company based in Abu Dhabi. It leverages TII’s globally ranked Falcon generative large language models to deliver secure, customizable enterprise-grade solutions with an initial focus on transforming medical diagnostics and clinical workflows. The company also targets educational and legal sectors. Its offerings include advisory services, custom solution design, model fine-tuning with proprietary data sets—including anonymized health data—and robust hosting options supporting data sovereignty. Early partnerships span government entities, global tech firms like AWS and World Wide Technology, consultancies such as PwC Middle East, academic institutions worldwide including collaborations with The World Bank and FAO. The first wave of products aims to improve accuracy in diagnosis while reducing time spent per patient through advanced automation tools like ASK71—an enterprise intelligence agent automating routine tasks so clinicians can focus more on patients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AI71.